Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: Cellular and neurochemical evidence

Neurotoxicity Research

Volumn 20, Issue 3, 2011, Pages 215-225

  Bishnoi, Mahendra ^a,d   Chopra, Kanwaljit ^b   Rongzhu, Lu ^c   Kulkarni, Shrinivas K ^a,b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

^c JIANGSU UNIVERSITY   (China)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase 3; Curcumin; Haloperidol; NF kappaB; Tardive dyskinesia

Indexed keywords

CASPASE 3; CLOZAPINE; CURCUMIN; DOPAMINE; HALOPERIDOL; NITRIC OXIDE; NORADRENALIN; PIPERINE; SEROTONIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CELL NUCLEUS; CELLULAR DISTRIBUTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; LONG TERM CARE; MALE; MOLECULAR PATHOLOGY; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NORADRENALIN BRAIN LEVEL; OROFACIAL DYSKINESIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; TREATMENT DURATION;

ALKALOIDS; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BENZODIOXOLES; CASPASE 3; COLORIMETRY; CURCUMIN; CYTOKINES; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HALOPERIDOL; INFLAMMATION; MALE; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; NEUROTRANSMITTER AGENTS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; STATISTICS AS TOPIC; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS;

EID: 84855644032     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-010-9229-4     Document Type: Article

References (77)

1. Aggarwal BB (2000) Tumor necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann Rheum D 59(Suppl 1):6-16
2. Aggarwal BB, Shishodia S (2004) Suppression of the nuclear factorkappaB activation pathway by spice-derived phytochemicals: Reasoning for seasoning. Ann N Y Acad Sci 1030:434-441 (Pubitemid 40378943)
3. Aggarwal BB, Shishodia S, Ashikawa K, Bharti AC (2002) The role of TNF and its family members in inflammation and cancer: Lessons from gene deletion. Curr Drug Targets Inflamm Allergy 1(4):327-341
4. Araujo CAC, Leon LL (2001) Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 6(5):723-728 (Pubitemid 33704182)
5. Arends MJ, Morris RG, Wyllie AH (1990) Apoptosis. The role of the endonuclease. Am J Pathol 136:593-608 (Pubitemid 20105927)
6. Atal CK, Dubey RK, Singh JJ (1985) Biochemical basis of enhanced drug bioavailability by piperine: Evidence that piperine is a potent inhibitor of drug metabolism. Pharmacol Exp Ther 232:258-262 (Pubitemid 15193683)
7. Babior BM, Kipner RS, Cerutte JT (1973) Biological defense mechanism. The production by leukocytes of superoxide, a potential bacterial agent. J Clin Investig 52:741-744
8. Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU, Mohan V (2003) Curcumin induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications. J Biosci 28:715-721 (Pubitemid 37522778)
9. Bishnoi M, Chopra K, Kulkarni SK (2007a) Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia-A biochemical and neurochemical study. Prog Neuropsychopharmacol Biol Psychiatry 31(5):1130-1138 (Pubitemid 46810111)
10. Bishnoi M, Kumar A, Chopra K, Kulkarni SK (2007b) Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: Implications in tardive dyskinesia. Indian J Exp Biol 45(2):175-179
11. Bishnoi M, Chopra K, Kulkarni SK (2008a) Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav 88:511-520
12. Bishnoi M, Chopra K, Kulkarni SK (2008b) Activation of striatal inflammatory mediators and caspase-3 is central to haloperidolinduced orofacial dyskinesia. Eur J Pharmacol 590(1-3): 241-245
13. Burger MBE, Fachineto R, Alves A, Callegari L, Rocha JBT (2005) Acute reserpine and sub-chronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats. Brain Res 1031(2):202-210 (Pubitemid 40103531)
14. Burkhardt C, Kelly JP, Lim YH, Filley CM, Parker WD (1993) Neuroleptic medications inhibit complex II of the electron transport chain. Ann Neurol 33:512-517 (Pubitemid 23143036)
15. Cara DB, Dusticier N, Forni C, Lievens JC, Daszuta A (2001) Serotonin depletion produces long lasting increase in striatal glutamatergic transmission. J Neurochem 78:240-248 (Pubitemid 32664405)
16. Cho JW, Lee KS, Kim CW (2007) Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 19(3):469-474
17. Church WH (2005) Column chromatography analysis of brain tissue: An advanced laboratory exercise for neuroscience majors. J Undergrad Neurosci Educ 3(2):A36-A41 (Pubitemid 40902202)
18. Cosi C, Waget A, Rollet K, Tesori V, Newman-Tancredi A (2005) Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: Role of 5-HT1A receptor activation. Brain Res 1043(1-2):32-41 (Pubitemid 40603369)
19. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262(5134):689-695 (Pubitemid 23350687)
20. Creese I, Burt D, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483
21. Cummings TJ, Walker PD (1996) Serotonin depletion exacerbates changes in striatal gene expression following quinolinic acid injection. Brain Res 743(1-2):240-248 (Pubitemid 27028777)
22. De Leon J, Susce MT, Pan RM, Koch WH, Wedlund PJ (2005) Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness. J Clin Psychopharmacol 25(5):448-456 (Pubitemid 41368367)
23. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77
24. Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ, Berry DP (2004) Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 90:1011-1015 (Pubitemid 38499692)
25. Guerin-Marchand C, Sénéchal H, Pelletier C, Fohrer H, Olivier R, David B, Berthon B (2001) H2O2 impairs inflammatory mediator release from immunologically stimulated RBL-2H3 cells through a redox-sensitive, calcium-dependent mechanism. Inflamm Res 150:341-349 (Pubitemid 32675395)
26. Guthmann F, Wissel H, Schachtrup C, Tölle A, Rüdiger M, Spener F, Rüstow B (2005) Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells. Respir Res 6:10
27. Hoehle SI, Pfeiffer E, Solyom AM, Metzler M (2006) Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agric Food Chem 54:756-764 (Pubitemid 43274111)
28. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH (2004) Apoptotic proteins in the temporal cortex in schizophrenia: High Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry 161:109-115 (Pubitemid 38419315)
29. Jarskog LF, Gilmore JH, Glantz LA, Gable KL, German TT, Tong RI, Lieberman JA (2007) Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. Neuropsychopharmacology 32:95-102 (Pubitemid 44967787)
30. Kikumori T, Kambe F, Nagaya T, Funahashi H, Seo H (2001) Thyrotrophin modifies activation of nuclear factor kappaB by tumor necrosis factor-alpha in rat thyroid cell line. Biochem J 354:573-579 (Pubitemid 32269720)
31. Lambert JD, Hong J, Kim DH, Mishin VM, Yang CS (2004) Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin- 3-gallate in mice. J Nutr 134(8):1948-1952 (Pubitemid 39031322)
32. Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Cavallaro R, Aschauer HN, McCreadie RG, Ohlraun S, Ferrier N, Masellis M, Verga M, Scharfetter J, Rietschel M, Lovlie R, Levy UH, Meltzer HY, Kennedy JL, Steen VM, Macciardi F (2002) Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 27(1): 105-119 (Pubitemid 34626747)
33. Liñares D, Taconis M, Maña P, Correcha M, Fordham S, Staykova M, Willenborg DO (2006) Neuronal nitric oxide synthase plays a key role in CNS demyelination. J Neurosci 26(49):12672-12681 (Pubitemid 44904562)
34. Liou YJ, Lai IC, Lin MW, Bai YM, Lin CC, Liao DL, Chen JY, Lin CY, Wang YC (2006) Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia. Pharmacogenet Genomics 16(3): 151-157
35. Lohr JB, Kuezenski R, Niculescu AB (2003) Oxidative mechanisms and tardive dyskinesia. CNS drugs 17(1):47-62 (Pubitemid 36044348)
36. Lowry OH (1951) Protein measurements with the Folin-phenol reagent. J Biol Chem 193:265-275
37. Madhavan L, Freed WJ, Anantharam V, Kanthasamy AG (2003) 5- Hydroxytryptamine 1A receptor activation protects against Nmethyl- D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures. J Pharmacol Exp Ther 304(3):913-923 (Pubitemid 36254401)
38. Mahakunakorn P, Tohda M, Murakami Y, Matsumoto K, Watanabe H, Vajaragupta O (2003) Cytoprotective and cytotoxic effects of curcumin: Dual action on H2O2-induced oxidative cell damage in NG108-15 cells. Biol Pharm Bull 26:725-728 (Pubitemid 39663572)
39. Müller DJ, Shinkai T, De Luca V, Kennedy JL (2004) Clinical implications of pharmacogenomics for tardive dyskinesia. Pharmacogenomics J 4(2):77-87 (Pubitemid 38499990)
40. Naidu PS, Singh A, Kulkarni SK (2003) Quercetin, a bioflavonoid attenuated haloperidol induced orofacial dyskinesia. Neuropharmacology 44:1100-1106
41. Pan MH, Huang TM, Lin JK (1999) Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486-494
42. Polydoro M, Schroder N, Lima MN, Caldana F, Laranja DC, Bromberg E, Roesler R, Quevedo J, Moreira JC, Dal-Pizzol F (2004) Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol Biochem Behav 78(4):751-756 (Pubitemid 39037735)
43. Post A, Holsboer F, Behl C (1998) Induction of NF-KB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: Suppression of NF-KB and neuroprotection by antioxidants. J Neurosci 15:8236-8246 (Pubitemid 28465001)
44. Post A, Rücker M, Ohl F, Uhr M, Holsboer F, Almeida OF, Michaelidis TM (2002) Mechanisms underlying the protective potential of alpha-tocopherol (vitamin E) against haloperidolassociated neurotoxicity. Neuropsychopharmacology 26(3):397-407 (Pubitemid 34159217)
45. Priyadarsini K, Maity D, Naik G (2003) Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic Biol Med 35:475-484 (Pubitemid 37289157)
46. Qin ZH, Chen RW, Wang Y, Nakai M, Chuang DM, Chase TN (1999) Nuclear factor KB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor apoptosis. J Neurosci 19:4023-4033 (Pubitemid 29222275)
47. Quiles JL, Mesa MD, Ramirez-Tortosa CL, Aguilera CM, Battino M, Gil A, Ramirez-Tortosa MC (2002) Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 22(7):1225-1231 (Pubitemid 34764878)
48. Rajeswari A (2006) Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur Rev Med Pharmacol Sci 10(4):157-161 (Pubitemid 44468939)
49. Ramos AJ, Rubio MD, Defagot C, Hischberg L, Villar MJ, Brusco A (2004) The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization. Brain Res 1030(2):201-220 (Pubitemid 39574953)
50. Rauscher FM, Sanders RA, Watkins JB (2000) Effects of piperine on antioxidant pathways in tissues from normal and streptozotocininduced diabetic rats. J Biochem Mol Toxicol 14(6):329-334
51. Reinke A, Martins MR, Lima MS, Moreira JC, Dal-Pizzol F, Quevedo J (2004) Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain. Neurosci Lett 372(1-2): 157-160 (Pubitemid 39505248)
52. Reynolds GP, Templeman LA, Zhang ZJ (2005) The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment. Prog Neuropsychopharmacol Biol Psychiatry 29(6):1021-1028 (Pubitemid 41080129)
53. Sagara Y (1998) Induction of reactive oxygen species in neurons by haloperidol. J Neurochem 71:1002-1012 (Pubitemid 28390254)
54. Saldaña M, Bonastre M, Aguilar E, Marin C (2006) Role of nigral NF-kappaB p50 and p65 subunit expression in haloperidolinduced neurotoxicity and stereotyped behavior in rats. Eur Neuropsychopharmacol 16(7):491-497 (Pubitemid 44311001)
55. Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G, Aggarwal BB (2007a) Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 43(4):568-580 (Pubitemid 47058232)
56. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB (2007b) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28(8):1765-1773 (Pubitemid 47289040)
57. Schaaf MJ, Willetts L, Hayes BP, Maschera B, Stylianou E, Farrow SN (2006) The relationship between intranuclear mobility of the NF-KB subunit p65 and its DNA-binding affinity. J Biol Chem 281(31):22409-22420 (Pubitemid 44181943)
58. See RE, Lynch AM (1995) Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex. Neuroreport 6(13):1795-1798
59. See RE, Lynch AM, Aravagiri M, Nemeroff CB, Owens MJ (1995) Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats. Brain Res 704(2):202-209 (Pubitemid 26009941)
60. Selvendiran K, Singh JP, Krishnan KB, Sakthisekaran D (2003) Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia 74(1-2):109-115 (Pubitemid 36287253)
61. Sethi G, Ahn KS, Sandur SK, Lin X, Chaturvedi MM, Aggarwal BB (2006) Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway. J Biol Chem 281(33):23425-23435 (Pubitemid 44274117)
62. Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: The story so far. Eur J Cancer (13):1955-1968 (Pubitemid 41557681)
63. Sharma RA, Steward WP, Gescher AJ (2007a) Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595:453-470
64. Sharma S, Chopra K, Kulkarni SK (2007b) Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: Participation of nitric oxide and TNFalpha. Phytother Res 21(3):278-283 (Pubitemid 46479679)
65. Shishodia S, Sethi G, Aggarwal BB (2005) Curcumin: Getting back to the roots. Ann N Y Acad Sci 1056:206-217 (Pubitemid 43030979)
66. Shishodia S, Chaturvedi MM, Aggarwal BB (2007) Role of curcumin in cancer therapy. Curr Probl Cancer 31(4):243-305 (Pubitemid 47077491)
67. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64(4): 353-356 (Pubitemid 28234275)
68. Singh S, Khanna M, Sarin JPS (1981) High pressure liquid chromatographic determination of Curcumin in biological fluids. Indian Drugs 18:207-209
69. Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao XM (1994) Clozapine in tardive dyskinesia: Observations from human and animal model studies. J Clin Psychiatry 55(Suppl B):102-106 (Pubitemid 24353029)
70. Terland O, Almås B, Flatmark T, Andersson KK, Sørlie M (2006) One-electron oxidation of catecholamines generates free radicals with an in vitro toxicity correlating with their lifetime. Free Radic Biol Med 41(8):1266-1271 (Pubitemid 44466323)
71. Tsai G, Goff DC, Wang RW, Flood J, Baer L, Coyle JT (1998) Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry 155:1207-1213 (Pubitemid 28402514)
72. Vijayakumar RS, Surya D, Nalini N (2004) Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox Rep 9(2):105-110 (Pubitemid 39010935)
73. Vilner BJ, Costa BR, Bowen WD (1995) Cytotoxic effects of sigma ligands: Sigma receptor-mediated alterations in cellular morphology and viability. J Neurosci 15:134-137
74. Wills ED (1966) Mechanism of lipid peroxide formation in animal tissues. Biochem Jour 99:667-676
75. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005a) The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 518(1):40-46 (Pubitemid 40968146)
76. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005b) Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82(1):200-206 (Pubitemid 41423504)
77. Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407:802-809